What Biofaktor does

Biofaktor is a privately held Polish pharmaceutical manufacturer founded in 2000, headquartered in Gorzów Wielkopolski with a GMP-certified production facility in Skierniewice and a sales office in Warsaw. The company operates three business divisions — Otolaryngology (human medical devices), CMO (contract manufacturing services), and Veterinary (medicines, nutritional supplements, and care products for animals) — and employs 51-100 people. Biofaktor manufactures pharmaceutical preparations in multiple dosage forms (liquids, powders, pills, tablets, creams, emulsions, gels, suppositories, and ovules) for both human and veterinary applications, with a veterinary portfolio spanning antibiotics (amoxicillin, doxycycline, tylosin, florfenicol, enrofloxacin), parasiticides, vitamins, probiotics, electrolytes, hepatoprotectants, and udder care products formulated for diverse species including poultry, cattle, pigs, sheep, goats, horses, dogs, cats, pigeons, carp, trout, ducks, and turkeys.

The company's underlying technology and quality system rests on multi-layered regulatory certification: GMP manufacturing standards, ISO 9001:2015 quality management, HACCP per Codex Alimentarius CXC 1-1969 (2020), LLOYD facility certification (2021), and most recently MDR Class IIb certification from TÜV Rheinland (0197) under EU Regulation 2017/745 for hyaluronic acid–based medical devices. Production capabilities support both proprietary branded products and third-party contract manufacturing from the Skierniewice site.

Biofaktor's business model combines B2B product sales with contract manufacturing services. Revenue is generated through one-time sales of veterinary medicinal products and human medical devices via a direct sales force and a dedicated export team covering Polish, English, Russian, Arabic, and Ukrainian markets, supplemented by CMO service contracts with pharmaceutical clients. Customer acquisition leverages field sales managers, an online B2B veterinary catalog with license-verified account registration, and participation in international trade fairs such as VIV SELECT TURKIYE 2025. Pricing is not publicly disclosed; quotes are provided on inquiry. The company maintains no disclosed funding history, no external venture investment, and no revenue disclosure, operating as an independently held Sp. z o.o. likely under founder/management control.

Name

Biofaktor

Legal name

Przedsiębiorstwo Zaopatrzenia Farmaceutyczno-Weterynaryjnego Biofaktor sp. z o.o.

Website

https://biofaktor.pl

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

51–100 employees

Short description

Biofaktor is a privately held Polish pharmaceutical manufacturer (founded 2000) producing veterinary medicines, nutritional supplements, and MDR-certified human medical devices, with a CMO division, operating from a GMP-certified facility in Skierniewice and serving domestic and international B2B customers.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Manufacturing, Private Label & Co-Manufacturing for Animal Diets (HLAMAHAO)

Keywords

• Veterinary pharmaceuticals
• Animal feed supplements
• Contract manufacturing
• Medical devices
• Dietary supplements

Headquarters

HQ city

Skierniewice

HQ country

Poland

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Veterinary Medicines and Preparations: Sale of veterinary medicinal products, animal feed supplements, nutritional preparations, and care products for farm animals (poultry, cattle, pigs, sheep, goats, horses) and companion animals (dogs, cats, pigeons). Revenue generated through direct B2B sales to veterinarians, breeders, and farms, with an online catalog and account registration system.
2. Human Medical Devices (Otolaryngology): Manufacturing and sale of medical devices (Class IIb MDR-certified) including rectal suppositories with hyaluronic acid and vaginal ovules with hyaluronic acid and lactic acid, targeted at proctology and women's intimate health markets in the EU.
3. Contract Manufacturing (CMO): Contract production services for pharmaceutical preparations under CMO (Contract Manufacturing Organization) arrangements, leveraging manufacturing facilities in Skierniewice certified to GMP standards.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

Biofaktor manufactures pharmaceutical preparations across three divisions: Otolaryngology (human medical devices with hyaluronic acid for proctology and women's intimate health), CMO (contract manufacturing services for pharmaceutical preparations), and Veterinary (medicines, nutritional preparations, and feed supplements for farm and companion animals). Production is carried out under GMP standards in multiple dosage forms at a LLOYD-certified facility in Skierniewice, Poland, serving both Polish and international B2B customers.

Differentiator

Problem solved

Functional benefit

Products and services

• Veterinary Medicines and Feed Supplements

Quantifiable outcome

• High product bioavailability and confirmed efficacy
• +2 more outcomes

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• VIV SELECT TURKIYE (Istanbul Expo Center)coreGTM or Marketing Partner · 1 April 2025Biofaktor participated as an exhibitor at the 11th edition of VIV SELECT TURKIYE (April 24–26, 2025) at Istanbul Expo Center, Hall 8, Stand C56. The company showcased veterinary preparations for poultry, new product innovations, and provided expert consultations to international visitors. This trade fair is a major international platform for poultry production technologies and represents a key GTM event for Biofaktor's international expansion.

Scale indicators8 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Norbrook Laboratories: Northern Ireland-based veterinary pharmaceutical manufacturer producing antibiotics, anti-inflammatories, parasiticides, and feed supplements for livestock and companion animals. Closely comparable to Biofaktor in its manufacturing-led veterinary pharma model and emphasis on multi-species antibiotic portfolios.
• Virbac: Global veterinary pharmaceutical company headquartered in France, producing vaccines, antibiotics, parasiticides, and specialty nutrition products for companion and farm animals. Closely aligned with Biofaktor's multi-species veterinary pharmaceutical portfolio and B2B distribution model.
• Dechra Pharmaceuticals: UK-listed veterinary pharmaceutical specialist focused on companion animal and equine products, plus food-producing animal medicines. Comparable to Biofaktor in its specialty pharma positioning across species and emphasis on regulated veterinary preparations.
• Vetoquinol: France-based global animal health pharmaceutical company focused on veterinary medicines and feed supplements for livestock and companion animals. Directly comparable to Biofaktor's veterinary division in product categories (antibiotics, parasiticides, supplements) and target customers (veterinarians, farmers, pet owners).
• Bimeda Animal Health: Privately held global animal health company manufacturing pharmaceuticals, vaccines, and nutritional products for livestock and companion animals. Comparable to Biofaktor as a similarly-sized private veterinary pharma manufacturer with broad species coverage and GMP-certified production.
• Ceva Santé Animale: French multinational animal health company offering pharmaceuticals, vaccines, and feed additives for livestock and companion animals. Comparable to Biofaktor in its pharmaceutical manufacturing focus across multiple species and its mix of own-label and contract production.
• Phibro Animal Health: US-listed animal health and nutrition company specializing in pharmaceuticals, feed additives, and nutritional supplements for livestock and poultry. Directly comparable to Biofaktor's emphasis on poultry/livestock medicines, feed supplements, and species-specific formulations.

Regional players

• Krka: Slovenian generic pharmaceutical manufacturer producing human and veterinary medicines, with a strong Central and Eastern European footprint. Comparable as a regional pharma manufacturer with multi-species veterinary products and contract manufacturing capabilities, though substantially larger than Biofaktor.
• Polpharma: Largest Polish pharmaceutical manufacturer producing human generics, OTC products, and APIs. Comparable as a Poland-headquartered pharma manufacturer with GMP facilities, though focused on human medicines rather than veterinary. Provides a regional benchmark for Polish pharma scale and capability.

Broad incumbents

• Zoetis: World's largest animal health company offering pharmaceuticals, vaccines, diagnostics, and feed additives across all major species. Relevant to Biofaktor as the dominant incumbent whose portfolio overlaps heavily with Biofaktor's veterinary medicines and nutritional products.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/9179675
• Facebookfacebook.com/biofaktor

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biofaktor